5 Crucial Insights into Low VWF QL: Uncovering a Distinct Cause of Bleeding
Blood Journals Portfolio, an official portfolio of ASH journals, shared a new sudy on X:
”Mild isolated functional VWF defects in the 30 to 50 IU/dL range are common and are associated with significant bleeding in some patients.”
Read the full article here.
The recently published article ‘Clinical phenotype and pathophysiological mechanisms underlying qualitative low VWF‘ by Ferdows Atiq et al. in Blood, sheds light on the significant complication risk for people with mild isolated VWF defects.
Emerging data from these combined cohorts in Ireland and Erasmus MC reveal that qualitative low von Willebrand factor (low VWF QL)—characterized by isolated reductions in VWF activity (30–50 IU/dL) despite normal antigen levels—accounts for approximately 50% of patients with low VWF.
Unlike type 2 von Willebrand disease (VWD), low VWF QL represents a distinct clinicopathological entity marked by significant bleeding phenotypes in many affected individuals.
Importantly, these functional defects are primarily driven by impaired VWF biosynthesis in endothelial cells, independent of known genetic variants.
These findings underscore the need for refined diagnostic approaches and tailored management for patients with mild functional VWF defects.
All the latest scientific advancements in the field of bleeding disorders featured in Hemostasis Today.
-
Sep 6, 2025, 14:04Chokri Ben Lamine – VTE Prophylaxis in Pregnancy (ASH 2018 Guidelines)
-
Sep 6, 2025, 13:48The Body Explained on Blood Clotting Pathways
-
Sep 5, 2025, 14:06Thrombosis Update: VTE Death Rate 3X Higher in Los Angeles Jails Than General Population
-
Sep 5, 2025, 10:59New Study Featured by Rare Disease Advisor Reveals Quality-of-Life Challenges in Hemophilia
-
Sep 4, 2025, 22:00Shivani Modi Highlights SOHO 2025 Study Linking Elevated WBC Counts to Increased Thrombosis Risk
-
Sep 6, 2025, 16:43Khaled Musallam: de-LIGHT Study on Use of Lifetime Anemia and Iron Control Index (LAICI) in Thalassemia Treatment
-
Sep 6, 2025, 15:06Managing Gynecologic Bleeding in Anticoagulated Patients: Toolkit Co-Authored by Divyaswathi Citla Sridhar
-
Sep 6, 2025, 14:30Mattia Galli on Whether Reduction in MACE Really Depicts Situation in Spontaneous MI or Death post-PCI
-
Sep 6, 2025, 13:55Patrick Cieran Gallogly and Colleagues on Atypical Symptoms in TIA and Minor Stroke
-
Sep 6, 2025, 13:37Unfractionated Heparin Dosing in ECMO: A Systematic Review and Meta-Analysis
-
Sep 2, 2025, 13:53Cost-Effective Strategies to Reduce Anaemia Highlighted in The Lancet Haematology
-
Sep 2, 2025, 13:04Ischemic Stroke or TIA Linked to Higher Femoral Fracture Risk
-
Sep 2, 2025, 12:51Treatment of Deep Brain AVMs Tied to Increased Hemorrhagic Stroke Risk
-
Aug 29, 2025, 09:03Vasculearn Network: New 2025 High Blood Pressure Guidelines Are Here
-
Aug 18, 2025, 23:56Dr. Arun V. J Invites You to His Lecture on ‘AI and Data Sciences in Transfusion Medicine’ at the AI in Healthcare Conclave. Register now!
-
Sep 6, 2025, 14:09Erin VanDyke: Shifting Attention Upstream in VTE Care Through NBCA Centers of Excellence
-
Sep 6, 2025, 12:02Caitlin Raymond on Kairos in Medicine: How Curiosity Sustains Physicians and Prevents Burnout
-
Sep 5, 2025, 14:12EAHAD Podcast: Reducing Pain and Distress in Children Receiving Emicizumab
-
Sep 5, 2025, 10:58Côme Bommier Recommends CRTH for Clinical Trial Training and Career Growth in Hematology
-
Sep 5, 2025, 10:55EHC This Way Webinar: Enhancing Joint Health Through Exercise - 8 Sept